Pre-teens need vaccine against sexually transmitted virus

According to a poll of doctors in the U.S., most would be prepared to give 11- and 12-year-old patients a vaccine to prevent infection with a sexually transmitted virus.

The survey by University of Colorado researchers was conducted as a result of concern on the part of practitioners, that many parents might refuse to vaccinate their children, for fear that the immunization might encourage risky sexual behavior in teenagers.

But it was found that only 11 percent of the pediatricians polled thought vaccination against a sexually transmitted disease would encourage promiscuous behavior.

The vaccine against the human papillomavirus, which causes most cervical cancers, may be licensed next year.

According to senior study author Nicole Liddon of the Centers for Disease Control and Prevention, in order for the vaccine to be fully effective, it would probably need to be given to adolescents before they had any sexual encounters.

Liddon presented the survey results to an Advisory Committee on Immunization Practices in Atlanta.

Health officials in the U.S. have been considering giving the vaccine at age 11 or 12, or even earlier.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
International study tests promising vaccine against 21 strains of pneumococcus